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CRISPR/Cas9 genome editing has revolutionized functional genomics in vertebrates. However, 
CRISPR/Cas9 edited  F0 animals too often demonstrate variable phenotypic penetrance due to the 
mosaic nature of editing outcomes after double strand break (DSB) repair. Even with high efficiency 
levels of genome editing, phenotypes may be obscured by proportional presence of in‑frame 
mutations that still produce functional protein. Recently, studies in cell culture systems have shown 
that the nature of CRISPR/Cas9‑mediated mutations can be dependent on local sequence context 
and can be predicted by computational methods. Here, we demonstrate that similar approaches can 
be used to forecast CRISPR/Cas9 gene editing outcomes in Xenopus tropicalis, Xenopus laevis, and 
zebrafish. We show that a publicly available neural network previously trained in mouse embryonic 
stem cell cultures (InDelphi‑mESC) is able to accurately predict CRISPR/Cas9 gene editing outcomes 
in early vertebrate embryos. Our observations can have direct implications for experiment design, 
allowing the selection of guide RNAs with predicted repair outcome signatures enriched towards 
frameshift mutations, allowing maximization of CRISPR/Cas9 phenotype penetrance in the  F0 
generation.
Over the last couple of years, CRISPR/Cas9 has revolutionized reverse genetic studies in non-mammalian ver-
tebrate model  organisms1–3, and has further empowered the use of Xenopus and zebrafish as model organisms 
for studying development and human  disease4–6. In particular,  F0 CRISPR/Cas9-mediated gene disruption in 
non-mammalian vertebrates has emerged as a cost-effective method to rapidly assign causality to genetic vari-
ants in candidate disease genes identified from human patient exome  sequencing7–11. This can assist clinical 
geneticists in providing timely genetic diagnosis and counseling to patients and affected families, thereby favoring 
societal and economic impact of findings. CRISPR/Cas9 mediated  F0 mosaic mutant embryos are also increas-
ingly employed as an alternative to antisense morpholino oligomers (MOs)12,13 to investigate gene function and 
genetic interactions in developing  embryos14, thus expanding the toolbox for cell and developmental biologists.
An important consideration in CRISPR/Cas9 mutational studies is identifying gRNAs that produce a high fre-
quency of loss-of-function mutations in the appropriate coding exons and hence generate highly penetrant spe-
cific  F0  phenotypes15. During gRNA design, considerations include the possibilities of reading frame preservation 
open
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upon skipping of the targeted exon or translation reinitiation at alternative start codons downstream of the gRNA 
cut site, culminating in retention of (partially) functional truncated protein  variants16,17. In coding exons, dou-
ble strand breaks (DSB) induced by CRISPR/Cas9 reagents are typically repaired by error-prone mechanisms, 
thereby potentially inducing frameshifting insertions and deletions (INDELs) resulting in premature stop-codons 
(PTC)18. Depending on their position in the primary mRNA, PTCs can subject the resulting transcript to non-
sense-mediated mRNA decay (NMD) and effective cellular knockout (KO) of the CRISPR/Cas9-targeted gene 
can thus be obtained. In contrast, in-frame INDELs in coding exons will lead to the loss or gain of amino acids, 
which can still result in retention of potentially functional protein  variants19. We believe that in many cases the 
inability to retrieve phenotypes in Xenopus and zebrafish  F0 CRISPR/Cas9 edited animals is the consequence of 
in-frame mutations in a substantial number of cells in the mosaic mutant animal. To circumvent this problem, 
targeting of gRNA to functional protein domains has been suggested and several tools have been released that 
allow actively integrating structural information in the gRNA design  process20,21. However, in-frame mutations in 
functional domains have the potential to generate dominant (e.g. gain-of-function) protein variants. Alternatively, 
simultaneous targeting of a single gene with multiple gRNAs has been suggested to produce high efficiency loss-
of-function8, but this method is associated with increased toxicity and magnifies off-target concerns inherent 
to the CRISPR/Cas9 system.
We, and others, hypothesized that improved gRNAs selection, with editing outcomes enriched for frameshift 
mutations and NMD, could maximize the penetrance of  F0  phenotypes22,23. It is now accepted that local sequence 
context surrounding the CRISPR/Cas9-induced DSB dictates editing outcomes and renders them  nonrandom24,25. 
DSB repair can be dependent on microhomology mediated end joining (MMEJ), and studies in zebrafish have 
shown that computational tools can be used to select guide RNAs likely to induce  MMEJ22,26. In parallel, several 
research groups have established computational prediction modules based on logistic regression or deep learning 
to anticipate, in silico, the outcomes of template-free CRISPR/Cas9 editing. Among these are InDelphi, Lindel 
and  FORECasT27–29, trained using large datasets of CRISPR/Cas9 editing outcomes in different cellular  contexts30. 
Here, we compared experimental outcomes of CRISPR/Cas9 genome editing in Xenopus and zebrafish embryos 
to these publicly available in silico editing outcome prediction models. We find that the InDelphi network that 
was trained on mouse embryonic stem cells (mESC) is highly predictive for the CRISPR/Cas9 editing outcomes 
in developing vertebrate embryos. We rationalize this will allow to select gRNAs favoring frameshift gene edit-
ing outcomes prone to nonsense-mediated decay (NMD), thereby maximizing subsequent protein knock-out 
in CRISPR/Cas9 animal models.
Results
The InDelphi mESC‑trained model accurately predicts the gene editing outcomes of CRISPR/
Cas9 in Xenopus tropicalis and outperforms other tested prediction models. In X. tropicalis, 
where CRISPR/Cas9 reagents are typically injected as a Cas9/gRNA-ribonucleoprotein complex at an early devel-
opmental stage (2 to 16 cell stage), rapid embryonic cell division will generate a spectrum of mosaic CRISPR/
Cas9 mutations, with dissimilar DSB repair events in different cells of the animal. This provides a unique oppor-
tunity to gain insight into how CRISPR/Cas9 DSBs are repaired in these vertebrate embryos. The ratios of cells 
within the mosaic presenting with certain INDEL variants is representative of the probabilistic outcomes of gene 
editing towards that specific mutation. In fact, there is a non-linear relation between the on-target gRNA ratio 
of frameshift editing and the percentage of biallelic mutant cells within the mosaic (Fig. 1A,B). When gRNA 
on-target efficiency reduces, this effect further inflates, leading to an ever-increasing contribution of cells in the 
developing embryo that still express functional protein of the gene under scrutiny (Fig. 1C).
We had previously observed significant correlation between experimental ezh2 CRISPR/Cas9 gene edit-
ing outcomes in X. tropicalis embryos, and the predictions obtained for the InDelphi model trained in mouse 
embryonic stem cell modus (further abbreviated as: InDelphi-mESC) (Fig. S1)31. We next questioned whether this 
observation would hold true in a larger dataset and also for other recently reported prediction models. For this, 
we analyzed the gene editing outcomes of 28 different gRNAs to 21 distinct genes injected individually as Cas9/
gRNA-ribonucleoproteins in X. tropicalis embryos. We employed targeted amplicon sequencing of the CRISPR/
Cas9 target sites to obtain experimental DSB repair outcomes at high-resolution in the injected  embryos32,33. This 
permitted us to compare in vivo gene editing outcomes in X. tropicalis embryos to the in silico predictions of four 
previously trained models: InDelphi-mESC, InDelphi adapted to HEK293T cellular context (further abbreviated 
as: InDelphi-HEK293T), Lindel (trained in HEK293T cells) and FORECasT (trained in K562 cells) (Fig. 1D)27–29. 
Please note that both InDelphi modules (mESC and HEK293T) make identical cell-type-independent predictions 
for deletions, while only using cell-type-specific data to predict the ratio of 1-bp insertions to  deletions27. First, 
we performed correlation analysis between model-predicted and experimentally observed cumulative frameshift 
gene editing frequencies, for each sgRNA separately (n = 28). Here, InDelphi-mESC demonstrated superior per-
formance (r = 0.89, p < 0.0001), when compared to the other prediction models: InDelphi-HEK293T (r = 0.84, 
p < 0.0001), Lindel (r = 0.73, p < 0.0001) and FORECasT (r = 0.72, p < 0.0001) (Fig. 2A). Second, we performed cor-
relation analysis between model predicted INDEL patterns versus experimentally observed frequencies of INDEL 
variants, for all gRNAs simultaneously. This revealed, in line with previous, superior predictive performance 
of InDelphi-mESC (r = 0.85, p < 0.0001), when compared to the other prediction models: InDelphi-HEK293T 
(r = 0.56, p < 0.0001), Lindel (r = 0.66, p < 0.0001) and FORECasT (r = 0.70, p < 0.0001) (Fig. 2B). Of note, lower 
frequency gene editing outcomes are predominantly mispredicted in HEK293T-specific predictions models.
Third, we analyzed the correlations between model predicted INDEL patterns to experimentally observed fre-
quencies of INDEL variants, for each gRNA separately. We show that InDelphi-mESC is able to accurately predict 
gene editing outcomes, for a single gRNA, in X. tropicalis embryos with an average Pearson correlation coefficient 
of 0.82 ± 0.12 (Fig. 2C; Fig. S2). As such, InDelphi-mESC outperforms InDelphi-HEK293T (r = 0.70 ± 0.17), Lindel 
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(r = 0.57 ± 0.19) and FORECasT (r = 0.64 ± 0.22) Pearson correlation coefficients. Interestingly, the comparison 
of model-predicted and experimentally observed mutations, revealed that HEK293T-specific predictions con-
sistently overestimate the frequency of + 1 insertions when compared to experimental editing outcomes in X. 
tropicalis embryos (Fig. 2D). Thus + 1 insertions appear to be a major editing outcome in HEK293T cells but less 
so in X. tropicalis embryos and mESC cells, which is reflected in their respective correlations (Fig. 2B,C). In line, 
the residuals between model-predicted and experimentally observed frequency of all deletion outcomes of gene 
editing, revealed that InDelphi also provides superior modeling of deletion outcomes compared to Lindel and 
FORECasT (Fig. 2E). Taken together, we show that the InDelphi-mESC model is capable of accurately predicting 
CRISPR/Cas9 gene editing outcomes occurring in vivo in early developing X. tropicalis embryos, upon micro-
injection of CRISPR/Cas9 ribonucleoprotein complexes. InDelphi-mESC significantly outperforms predictive 
models trained in more differentiated cell lines.
Accurate correlations between gene editing outcomes predicted by InDelphi‑mESC and 
in vivo gene editing outcomes determined by Sanger sequencing and sequence trace decon‑
volution in two species of Xenopus. To validate and extend our observations beyond a possible labora-
tory-dependent bias for gRNA selection and by using alternatives for targeted amplicon sequencing approaches, 
we compared InDelphi-mESC predictions to experimental gene editing outcomes in X. tropicalis (n = 14) and 
X. laevis (n = 10), determined by Sanger sequencing and sequence deconvolution analysis with the Inference of 
CRISPR Edits (ICE)  algorithm34. In X. tropicalis embryos, InDelphi-mESC was also able to accurately predict 
the experimental cumulative frequency of frameshift editing, for each gRNA separately (r = 0.87; p < 0.0001) 
(Fig. 3A), as well as INDEL patterns across all gRNAs simultaneously (r = 0.80; p < 0.0001) (Fig. 3D). Further, 
Figure 1.  Theoretical models of how gRNA-specific efficiencies and frameshift gene editing outcome 
probabilities influence the cellular composition and percentage of protein knockout cells in a mosaic  F0 animal 
model. (A) There is a non-linear relationship between gRNA-specific probability of obtaining a frameshift 
gene editing outcome (x-axis) and the probability of obtaining a biallelic frameshift gene editing outcome in a 
single cell (y-axis). E.g. upon a gRNA-specific frameshift frequency of 80%, the probability of a single biallelic 
edited cells to be biallelic frameshift mutant is 64% (0.80*0.80). (Grey demarcation). (B) Examples of theoretical 
outcomes of gene editing (presuming 100% on-target efficiency) in an  F0 mosaic varying one parameter: 
gRNA-specific probability of frameshift editing. (C) Examples of theoretical outcomes of gene editing in an  F0 
mosaic varying two parameters: gRNA-specific probability of frameshift editing and gRNA-specific on-target 
efficiency. E.g. for a 100% efficient gRNA with an 80% gRNA-specific probability of frameshift editing, we 
expect 64% of the cells to be biallelic frameshift mutant (see grey demarcation in A). Please note, blue circles 
represent cells that are biallelic gene edited, but retain at least one in-frame mutation and cannot be considered 
complete protein knock-out. (D) Flowchart representing the pipe-line for investigating the correlations between 
experimentally observed in vivo gene editing outcomes and gene editing outcomes projected by computational 
prediction models.
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Figure 2.  The InDelphi prediction model, trained in mESC cells, accurately predicts CRISPR/Cas9 gene 
editing outcomes and outperforms several other prediction models in X. tropicalis embryos. (A) Scatter plot 
with model-predicted cumulative frameshift gene editing frequencies correlated to experimentally observed 
cumulative frameshift gene editing frequencies, for each sgRNA (n = 28) separately, in X. tropicalis embryos. 
Black demarcated lines show the perfect correlation r = 1. Light-grey shows the standard error of the best-fit 
linear regression line. (B) Scatter plot with model-predicted INDEL patterns correlated to experimentally 
observed INDEL patterns, for all gRNAs simultaneously. Black lines show linear regression models of all 
correlations. Black demarcated lines show the perfect correlation r = 1. (C) Correlations between model-
predicted and experimentally observed INDEL patterns, for each gRNA separately. Error bars represent 
mean ± SD. (***p < 0.001; **p < 0.01; *p < 0.05; ns = not significant; Shapiro–Wilk (p > 0.05); Levene (p < 0.05); 
One-way Welsh ANOVA to adjust for unequal variances (p < 0.001), with Games-Howell multiple comparisons) 
(Table S2). (D) Violin plots of the residuals (predicted frequency—observed frequency) between model-
predicted and experimentally observed frequency of + 1 insertion gene editing outcome. (E) The SEM of 
the mean residual difference (predicted frequency—observed frequency) between model-predicted and 
experimentally observed frequency of all deletion variants modeled.
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InDelphi-mESC-predicted INDEL patterns correlate with the frequencies of experimentally observed INDEL 
patterns in the developing X. tropicalis embryo, for each gRNA separately (r = 0.73 ± 0.20) (Fig. 3G, Fig. S3).
Next, we tested whether these observations could be expanded to Xenopus laevis embryos. Using an identical 
injection and Sanger sequence deconvolution approach, we observed that 60% (n = 10) of gRNAs showed sig-
nificant (p < 0.05) Pearson correlations (r = 0.76 ± 0.16) between InDelphi-mESC-predicted and experimentally 
observed INDEL patterns (Fig. 3G; Fig. S4). We speculate that the lack of correlation for the remaining four 
gRNAs in X. laevis is the consequence of underpowered in vivo observations of the heterogeneous outcomes of 
gene editing. Namely, in the slower developing X. laevis embryos, it can be rationalized that gene editing will 
occur at an earlier developmental stage than is the case for X. tropicalis and this will lead to a lower number of 
discrete DSB repair events and thereby a lower degree of mosaicism. This interferes with the premise that the 
mosaicity of the early embryo is representative to the probabilistic outcomes of gene editing towards a specific 
variant. Despite these limitations, gRNAs with sufficiently-powered experimental gene editing outcome observa-
tions (n = 6), featured accurate prediction of experimental cumulative frequency of frameshift editing, for each 
gRNA separately (r = 0.90; p < 0.05) (Fig. 3B), and INDEL patterns across all gRNAs simultaneously (r = 0.85; 
p < 0.0001) by InDelphi-mESC (Fig. 3E).
Taken together we show that, in some cases (n = 4) Sanger sequencing and sequence trace deconvolution on 
a limited subset of embryos, can lack power for quantitatively assessing heterogeneous gene editing outcomes 
occurring in vivo. Despite this limitation, we demonstrate significant correlations between InDelphi-mESC 
model predicted gene editing outcomes and experimental editing outcomes for 83% (n = 24) of gRNAs across 
both X. laevis and X. tropicalis using Sanger sequencing and trace deconvolution.
InDelphi mESC‑trained model accurately predicts the gene editing outcomes of CRISPR/Cas9 
in zebrafish and allows for rational gRNA design to favor high frameshift frequency gene edit‑
ing outcomes. Finally, we investigated whether InDelphi-mESC can also predict gene editing outcomes 
in the evolutionary more distant teleost phylogenetic lineage. For this, we compared InDelphi-mESC model 
predictions to in vivo gene editing outcomes in zebrafish embryos, identified by targeted amplicon  sequencing32, 
upon micro-injection of CRISPR/Cas9 ribonucleoproteins (n = 15). Once again, we demonstrate that InDel-
phi-mESC is able to accurately predict cumulative frameshift frequencies, for each gRNA separately (r = 0.62; 
p < 0.05) (Fig. 3C), and INDEL patterns across all gRNAs simultaneously (r = 0.73; p < 0.001) (Fig. 3F). In line, 
the INDEL pattern gene editing outcomes, for each gRNA separately, are also predictable by the InDelphi-mESC 
model (r = 0.80 ± 0.12) (Fig. 3G, Fig. S5).
Integrating CRISPRscan and the InDelphi‑mESC model allows identification of efficient high 
frameshift frequency gRNAs in X. tropicalis. In order to investigate the possible application of InDel-
phi (together with CRISPRscan) for efficient gRNA design in future experimental settings, we calculated CRIS-
PRscan scores, InDelphi-mESC predicted frequency of MMEJ repair and InDelphi-mESC predicted knockout-
score (KO-score) for 339,693 gRNAs across the coding sequence for 4,860 X. tropicalis genes. The KO-score is 
defined as the predicted percentage of cells with biallelic out-of-frame mutations within the pool of all mutant 
cells (i.e. in-frame and out-of-frame; mono- and bi-allelic) in the mosaic mutant embryo and is calculated as 
the square of the frameshift frequency predicted by InDelphi-mESC (Fig. 4A). We identified for each of these 
individual genes: the guide RNA with the highest predicted KO-score (annotated as ‘highest-in-class’, Fig. 4A—
blue), the lowest predicted KO-score (annotated as ‘lowest-in-class’, Fig. 4A—orange), on a background of all 
possible gRNAs targeting these genes (Fig. 4A—grey). When comparing the highest-in-class and lowest-in-class 
gRNA for each gene to a random sample of 4,860 gRNAs, we observe enrichment towards an increased repair 
by microhomology-mediated mechanisms (p < 0.0001) (Fig.  4B). Nevertheless, only 5.3% of highest-in-class 
gRNAs exceed a threshold of over 90% repair by MMEJ (Fig. 4A—green demarcated). This indicates that only 
considering local MMEJ strength as a factor for maximizing phenotypic penetrance could be insufficient as 
frameshifting mutations can also be enriched for gRNAs producing heterogeneous editing outcomes. Next, we 
investigated the CRISPRscan scores as a measure for predicted in vivo editing efficiencies for these highest-in-
class guides, expected to be the best candidates for maximizing phenotypic penetrance. This revealed that, as 
expected, highest-in-class, lowest-in-class and a random selection of 4,860 gRNAs have similar CRISPRscan 
score distributions (Fig.  4C). In practice, merely considering CRISPRscan score during gRNA design could 
be insufficient to obtain a high KO phenotype. In fact, we observe that gRNAs scoring well on CRISPRscan 
(score > 50) can have a low predicted KO-score and some can even be characterized as lowest-in-class for that 
gene (Fig. 4A, orange demarcated). Conversely, only considering KO-score could be similarly insufficient as 
these gRNAs could have a low CRISPRscan score, yielding lack of in vivo effectiveness (Fig. 4A, purple demar-
cated). In conclusion, we determine that 30% of the screened genes (n = 4,860) have a highest-in-class gRNA 
with a KO-score exceeding 75 and a CRISPRscan score exceeding 50, a score considered sufficient for efficient 
in  vivo editing (Fig.  4A, aquamarine demarcated). For the remaining genes, guides can be identified with a 
slightly lower predicted KO-score, but with CRISPRscan scores exceeding this threshold. It is worth noting that 
sacrificing some of the CRISPRscan score in order to obtain a gRNA with a higher predicted KO-score is benefi-
cial, as cutting efficiency can be improved in an experimental setup by increasing the injected dose of CRISPR/
Cas9 RNP. In contrast, the frameshift frequency pattern of the chosen gRNA is inherent to its sequence context 
and cannot be altered experimentally.
In order to relate phenotype penetrance variability to different predicted KO-scores, we targeted the second 
exon of the tyrosinase (tyr) gene using six distinct gRNAs. For this, each tyr gRNA respectively was coinjected 
with Cas9 recombinant protein in both blastomeres of two-cell stage X. tropicalis embryos. Absence of retinal pig-
mentation was used as a proxy for the efficiency of tyr biallelic frameshift editing. Targeted amplicon sequencing 
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revealed very similar genome editing efficiencies between tyrgRNA1 and tyrgRNA2 (low—around 14%), tyrgRNA3 and 
tyrgRNA4 (medium—around 34%), tyrgRNA5 and tyrgRNA6 (high—around 68%) (Fig. 4C, Table S3). The similar gene 
editing efficiencies within these three pairs allows directly measuring the impact of the predicted KO-scores on 
phenotypic penetrance. Quantification of residual eye pigmentation at Nieuwkoop-Faber stage 38 revealed a 
clear trend where guides with higher predicted KO-scores consistently yielded a higher phenotypic score under 
very similar genome editing efficiencies (Fig. 4D-E, Fig. S6). This in vivo functional experiment strengthens our 
notion that selecting a gRNA with a predicted high frameshift frequency using the InDelphi-mESC model can 
help maximize CRISPR/Cas9 phenotypic penetrance.
Discussion
In this manuscript we investigated the power of three established computational prediction modules for antici-
pating template-free CRISPR/Cas9 editing outcomes in three vertebrate species commonly used as biomedical 
model organisms. We show the InDelphi neural network mESC module to accurately forecast CRISPR/Cas9 
editing outcomes in embryos of Xenopus and Danio rerio. Our observations strengthen the developing paradigm 
that double-strand break repair after template-free CRISPR/Cas9 editing is predictable, but may proceed in a 
cell-type specific manner. We hypothesize that the undifferentiated pluripotent state of mESC cells, wherein 
InDelphi-mESC was trained, most closely resembles the epigenetic, transcriptomic and post-transcriptional 
context of an early developing pluripotent vertebrate embryo. This directly impacts rational design of CRISPR/
Cas9 experiments, implementing in the design process selection of gRNAs that favor frameshift gene editing 
outcomes, thereby improving  F0 knockout studies. Ideally, the InDelphi-mESC model is exploited to identify 
“precise” gRNAs with inherently precise editing outcomes, defined as homogeneous DNA repair outcomes and 
enrichment for specific frameshift variants. Namely, our data shows that the InDelphi-mESC model is able to 
accurately predict in vivo CRISPR/Cas9 gene editing outcomes, only based on local sequence context, in early 
embryos of different vertebrate species commonly used as model organisms.
We suggest using the InDelphi-mESC model to cherry-pick gRNAs predicted to yield high rates of frameshift 
gene editing outcomes, allowing maximization of protein knockout in vertebrate  F0 mosaic CRISPR/Cas9 edited 
animals and thereby increasing phenotypic penetrance. When InDelphi-mESC is employed to predict frameshift 
frequencies occurring at 13,273,449 SpCas9 human target sites after CRISPR/Cas9  editing27, mathematical mod-
eling reveals that a randomly designed gRNA, with assumed full on-target efficiency, only has a 3.24% theoreti-
cal probability of resulting in equal or larger than 80% of the cells in the  F0 mosaic being biallelic frameshift 
mutations (Fig. 3H)27. As most gRNAs will not reach full on-target efficiency, this effect will become even more 
pronounced in an in vivo setting. This clearly illustrates the advantage of selecting gRNAs with high frameshift 
prediction for exposing phenotypes in  F0 mosaic animals. In addition, when breeding  F0 animals generated using 
precise gRNAs, a major contribution of predominant gene editing outcomes to the germline can be expected. 
Implementation of InDelphi-mESC in the gRNA design process should facilitate the generation of frameshift 
heterozygous mutant  F1 animals upon out breeding, and potentially accelerate the creation of homozygous 
mutant  F1 animals by directly breeding  F0 founders. In addition, genome editing outcome predictions are use-
ful to determine both positive and negative selection pressure on cellular fitness occurring as a consequence of 
underlying biological processes, such as—but not limited to—tumorigenesis and  cancer31,35.
Recently, for gene knockout studies, the use of frameshift-inducing gRNAs that cause nonsense-mediated 
decay (NMD) of the transcript has been contested. Using experiments in zebrafish and mouse embryonic stem 
cells, it was found that some CRISPR mutated transcripts that are subjected to NMD are able to induce tran-
scriptional adaptation and compensation resulting in a less severe  phenotype36. Hence, complete deletion of the 
targeted gene by deploying flanking gRNAs has been advocated. However, the underlying mechanism, while 
being clearly sequence-determined, still is poorly defined. Hence, at the moment it remains to be seen how 
universal this phenomenon is. Additionally, a major concern for deleting large or complete parts of a particular 
Figure 3.  The InDelphi-mESC model accurately predicts CRISPR/Cas9 gene editing outcomes in X. tropicalis, 
X. laevis and zebrafish embryos which can be exploited to identify high-frameshift frequency gRNAs. (A–F) 
Scatter plot with InDelphi-mESC-predicted cumulative frameshift gene editing frequencies correlated to 
experimentally observed cumulative frameshift gene editing frequencies, for each sgRNA separately, in X. 
tropicalis (n = 14) (Panel A), in X. laevis (n = 6) (Panel B) and in zebrafish (n = 15) embryos (Panel C). Scatter 
plot with InDelphi-mESC-predicted INDEL patterns correlated to experimentally observed INDEL patterns, for 
all gRNAs simultaneous, in X. tropicalis (n = 14) (Panel D), in X. laevis (n = 6) (Panel E) and zebrafish (n = 15) 
(Panel F) embryos. Black demarcated lines show the perfect correlation r = 1. Light-grey areas show the standard 
error on the best-fit linear regression line. Black lines show linear regression model. (G) Correlations between 
model-predicted INDEL patterns to experimentally observed INDEL patterns, for each gRNA separately. 
Correlations for X. tropicalis embryos (n = 14) (dark blue) and X. laevis embryos (n = 6) (middle blue) analyzed 
by Sanger sequencing and sequence trace decomposition. Correlations for zebrafish embryos analyzed by 
targeted amplicon sequencing (TAS) (n = 15) (light blue). (H) Using the distribution of the expected probability 
of frameshift frequency for a large dataset of SpCas9 human target sites in mESC cells from Shen et al. 2018 
(black line—monoallelic)27, we draw the derivative distribution of the probability of a randomly designed gRNA 
to generate biallelic frameshift editing. This distribution is shown for different editing efficiencies within the 
 F0 mosaic animal: 100%, 50% and 25% (in reducing intensities of blue—100 circles, each circle represents a 
cell within a total mosaic of a 100 cells). E.g. The probability of a randomly designed gRNA to yield more than 
80% biallelic frameshift mutant cells in a developing mosaic, assuming 100% efficiency, is the area under curve 
highlighted in pink and represents only a 3.24% probability.
◂
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gene is the concomitant removal of possible intronic non-coding regulatory elements and RNAs, which can add 
to off-target concerns already inherent to the CRISPR/Cas9 system.
Evidently, predictions of gene editing outcomes can also be harnessed to specifically design gRNAs with 
known dominant or loss-of-function in-frame mutations. This can be exploited for structure–function studies 
of protein variants in a cell or development biology  context19. Obviously, the analysis of such experiments would 
be challenging in the  F0 generation but achieving dominant editing of specific in-frame variants heavily increases 
the chance of passing the exact genotype of interest to the  F1 generation. Furthermore, to deal with the pos-
sible NMD-induced transcriptional adaptation and compensation mentioned above, it was recently argued that 
the use of gRNAs selecting for in-frame mutations in domains essential for protein function could be another 
approach to produce loss-of-function  alleles37. In this scope, InDelphi could similarly be employed to identify 
gRNAs with high predicted in-frame frequencies (our lowest-in-class gRNAs). In conclusion, we show that the 
InDelphi-mESC model allows for the rational design of gRNAs that have high efficiency CRISPR/Cas9-mediated 
loss-of-function INDEL mutations in vertebrate developing embryos, allowing to maximize  F0 and  F1 phenotype 
penetrance. Evidently gRNA design should also integrate prediction of cutting efficiency (e.g. via CRISPRscan). 
We believe these findings to have direct implications for Xenopus and zebrafish CRISPR/Cas9 genome engineer-
ing and should be included in the standard guide RNA design process.
Material and methods
Guide RNA synthesis and microinjection. For the Xenopus tropicalis experiments, gRNAs were 
designed with the CRISPRscan software  package15, generated and quality controlled as previously  described23, 
employing the oligos shown in supplementary table S1A. When using AltR-crRNA from Integrated DNA Tech-
nologies (IDT, USA), crRNA was annealed with AltR-tracrRNA prior to injections according to the guidelines of 
the company. Recombinant Cas9 protein was commercially obtained (PNA Biosciences) or in-house generated 
as previously  described38. Xenopus tropicalis embryos were microinjected in either the one-, two- or four-cell 
stage with injection mixes containing precomplexed gRNA (500–750 pg) and Cas9 protein (1 ng). Embryos 
were lysed for 2 h up to overnight in lysis buffer (50 mM Tris pH 8.8, 1 mM EDTA, 0.5% Tween-20, 2 mg/ml 
Proteinase K) and genotyped by PCR amplification using primers indicated in supplementary table  S1A. In 
the Xenopus laevis experiments the gRNAs were designed with the CRISPRscan (https ://www.crisp rscan .org) 
or CRISPRdirect (https ://crisp r.dbcls .jp) software package (Table S1B)15,39. These were secondarily verified for 
no or low potential of off-targets with GGGenome (https ://gggen ome.dbcls .hp/) using the most up to date ver-
sion of the X. laevis genome available at the time of gRNA design. Recombinant NLS-Cas9-NLS protein was 
purified and the sgRNAs synthesized in the Horb lab. Embryos were injected at one cell stage with 10 nl of a 
mix containing 0.1% of TexasRed dextran (40,000 MW, neutral) (Invitrogen, Eugene, OR), 1.5 ng Cas9 protein 
and 0.75  ng of sgRNA. One- or two-days post injection genomic DNA was extracted from whole embryos 
(GenElute Mammalian Genomic DNA Miniprep Kit, Sigma-Aldrich, St. Louis, MO), the target regions were 
PCR amplified (Taq DNA Polymerase, New England Biolabs, Ipswich, MA) using primers indicated in sup-
plementary table  S1B, the PCR products were cleaned (EconoSpin Spin Column For DNA, Epoch Life Sci-
ence, Missouri City, TX) and sent for Sanger sequencing (GENEWIZ, South Plainfield, NJ). For the zebrafish 
experiments, single-guide RNA (sgRNA) molecules were designed with the CRISPRdirect software (https ://
crisp r.dbcls .jp/)36, and were produced as previously  reported31. Briefly, in vitro transcription (MEGAshortscript 
T7 Transcription Kit, Invitrogen, cat. nr. AM1354) was carried out on target-specific double-stranded DNA 
molecules (gBlocks), followed by RNA purification (MEGAclear Kit, Life Technologies, cat. nr. AM1908) and 
quantity and integrity assessment. One-cell stage zebrafish embryos were injected with CRISPR/Cas9 compo-
nents in the cell, as previously  described31. At 1-day post fertilization (dpf), DNA extraction was performed on a 
pool of 20 embryos (KAPA Express Extract DNA Extraction Kit, Kapa Biosystems, KK7103). The resulting DNA 
Figure 4.  Integrating CRISPRscan and the InDelphi-mESC model allows identification of efficient high 
frameshift frequency gRNAs in X. tropicalis. (A) Scatterplot with marginal histograms demonstrating for 
339,693 gRNAs across the coding sequence for 4,860 X. tropicalis genes the relationships between calculated 
CRISPRscan score, InDelphi-mESC predicted frequency of MMEJ repair and InDelphi-mESC predicted 
knockout-score (KO-score). KO-score is defined as the predicted percentage of cells with biallelic out-of-frame 
mutations within the pool of all mutant cells (i.e. in-frame and out-of-frame; mono- and bi-allelic) in the mosaic 
mutant embryo and is calculated as the square of the frameshift frequency predicted by InDelphi-mESC. For 
each gene (n = 4,860), the gRNA with the highest predicted KO-score (Highest-in-class) is highlighted in blue, 
while the gRNA with the lowest predicted KO-score (Lowest-in-class) is highlighted in orange. Demarcations 
illustrate those quadrants where gRNAs suffice to certain cutoff thresholds. Ideally, designed gRNAs fall within 
the aquamarine demarcation (high predicted KO-score, high CRISPRscan score), but not the orange (low 
predicted KO-score, high CRISPRscan score) or purple demarcation (high predicted KO-score, low predicted 
CRISPRscan score). (B) Violin plot illustrating that highest-in-class gRNAs and lowest-in-class gRNAs have 
a higher predicted percentage of repair by microhomology-mediated end joining than a random selection of 
guides. (****p < 0.001—Table S2). (C) No distinct difference in calculated CRISPRscan scores between highest-
in-class gRNAs, lowest-in-class gRNAs and a random selection of gRNAs. (D) Comparison of three pairs 
of gRNAs targeting the second exon of the tyrosinase gene responsible for pigmentation in X. tropicalis. As 
these three pairs of guides have very similar genome editing efficiencies, as determined by targeted amplicon 
sequencing, the impact of differential predicted KO-scores on phenotypic penetrance is revealed. (D, E) 
Phenotypic scoring is based on retinal pigmentation at Nieuwkoop-Faber stage 38 and a trend is observed where 
guides with higher predicted KO-scores yield a higher phenotypic score under very similar genome editing 
efficiencies.
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was stored at -20 °C for subsequent targeted PCR amplification and deep sequencing using primers indicated in 
supplementary Table S1C. For quantification of loss of eye pigmentation in tyrosinase RNP injected X. tropicalis, 
pictures where acquired with a Carl Zeiss StereoLUMAR.V12 stereomicroscope equipped with an AxioCam 
MRc using Zen Blue and processed as follows for quantification. Pictures were cropped maintaining all voxel 
ratios to 365 × 365 pixels to contain only the eye. Using thresholding we masked the pigmented part of the eye 
for quantification using following FIJI macro: [run("8-bit"); setThreshold(1, 30); setOption("BlackBackground", 
true); run("Convert to Mask"); run("Analyze Particles…", "display summarize");]. Quantification of masked pix-
els generated values between 4,011 and 79,408. All measurements were normalized to the most pigmented eye 
using following formula: [(79,408-masked_pixels)/79,408]. For genotyping of tyr mutants, single embryos where 
lysed and processed for targeted amplicon sequencing identical as described above.
Comparison of in vivo CRISPR/Cas9 editing outcomes to in silico prediction models. All tar-
geted amplicon sequencing was performed and analyzed as previously  described33. For InDelphi modeling 
(https ://InDel phi.giffo rdlab .mit.edu/)27, sequence context input was 80 bp (40 bp upstream and 40 bp down-
stream of the cleavage site) in both mESC and HEK293T input mode. For correlation between InDelphi pre-
dictions and in vivo observations, wild-type reads and reads containing insertions > 1 were omitted from the 
experimental sequencing results to allow comparison to InDelphi predictive modeling software output. Residual 
reads were normalized to 100% to obtain experimentally observed frequencies for each retained mutant read 
variant, which were correlated to in vivo observations using Pearson correlation. For FORECasT and Lindel 
modeling, sequence context input was 65 bp (30 bp upstream and 35 bp downstream of the cleavage site) and 
ran respectively in the GUI (https ://parts lab.sange r.ac.uk/FOREC asT) or in the command line of Python3 using 
GitHub-deposited code (https ://githu b.com/shend urela b/Linde l)29,40. To allow direct comparison of the predic-
tive strengths of these different models, we curated all predictions to be in-line with the editing outcome classes 
of the InDelphi model, thus comparing the frequencies of gene editing outcomes containing insertions + 1 bp 
up to the deletion that exceeds the combined 99% cumulative probability of all events using InDelphi in mESC 
mode. This approach disfavors disproportionate weighting of low-frequency large deletion variants in the Pear-
son correlation. All correlations were performed using Pearson correlation imbedded in the GraphPad Prism 
software package. For Sanger sequencing and trace deconvolution we employed the ICE algorithm (Synthego—
available from: https ://ice.synth ego.com/)34. Raw Sanger data was implemented in the ICE algorithm for both 
the wild type control as well as the injected samples along with the applicable gRNA sequence. For every gRNA, 
generated ICE data from at least three different injected embryos was averaged out and frequencies were normal-
ized (as such containing all 1 bp insertions and up to 20 bp deletions) and correlated to the InDelphi predictions 
(mESC input mode). Statistical analysis in relation to Fig. 2C performed with SPPS software version 26 (IBM).
Identifying gRNAs in 4,860 X. tropicalis genes and predicting in vivo editing outcomes and 
CRISPRscan scores. InDelphi-mESC pretrained model was obtained (https ://githu b.com/maxws hen/
inDel phi-model ) and deployed using scikit-learn v0.21.3. CRISPRscan sgRNA activity regression model was 
implemented as described in Moreno-Mateos et  al.15. Using a custom Python3 pipeline, guide RNAs were 
designed across the first 4,860 entries of the coding sequences (CDS) of the X. tropicalis v9.1 genome assembly 
obtained from Xenbase (https ://ftp.xenba se.org/pub/Genom ics/JGI/Xentr 9.1/seque nces/XENTR _9.1_Xenba 
se.cds.fa)41. For each of the 4,860 entries gRNAs compatible with T7 transcription were retained, scored with 
CRISPRscan, analyzed using the InDelphi mESC model to determine frameshift frequency and the percent-
age of repair by MMEJ. Knockout-score (KO-score) is defined as the square of the InDelphi-mESC predicted 
frameshift frequency. For each gene the gRNA with the highest predicted KO-score (highest-in-class) and the 
lowest predicted KO-score (lowest-in-class) was determined. Further data analysis to obtain percentages of 
gRNAs accommodating certain CRISPRscan or KO-score thresholds was performed using Pandas v0.25.1. All 
data was visualized using the Altair v4.0.1 package.
Ethical statement. Experiments in Xenopus tropicalis were performed using guidelines approved by the 
CCHMC Institutional Animal Care and Use Committee (IACUC2019-0,053) and the Ethical Committee for 
Animal Experimentation, Ghent University, Faculty of Science and VIB-Site Ghent (EC2018-079). All animal 
experiments with Xenopus performed at the National Xenopus Resource were approved by the MBL Institu-
tional Animal Care and Use Committee (19–03). Approval for zebrafish experiments was provided by the local 
committee on the Ethics of Animal Experiments (Ghent University Hospital, Ghent, Belgium). Experiments in 
zebrafish were performed according to the guidelines outlined in Permit Number: ECD 14/31 and ECD 17/41.
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